Science abstracts on ウェルネス
- Safety and side effects of cannabidiol
- CBD: From an inactive cannabinoid to a drug with wide spectrum of action
- CBD as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
- CBD: An overview of some pharmacological aspects
- CBD: An overview of some chemical and pharmacological aspects
- The endocannabinoid system as an emerging target of pharmacotherapy
- Therapeutic potential of cannabinoid-based drugs
- Targeting the endocannabinoid system with cannabinoid receptor agonists
- Cannabis-based medicines–GW pharmaceuticals
- The therapeutic potential of cannabis and cannabinoids
- Emerging strategies for exploiting cannabinoid receptor agonists as medicines
- Therapeutic potential of cannabinoid-based drugs
- Cannabinoids in clinical practice
- Cannabinoids
- Pharmacology of cannabinoids
- Combined cannabinoid therapy via an oromucosal spray
- Non-psychotropic plant cannabinoids
- Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology
- Care and feeding of the endocannabinoid system
- Understanding the molecular aspects of THC and CBD as antioxidants
- A tale of two cannabinoids
- Clinical studies with cannabis and cannabinoids, 2005-2009
- An update on safety and side effects of CBD: A review of clinical data and relevant animal studies
- Explorative Placebo-Controlled Double-Blind Intervention Study with Low Doses of InhaledTHC and CBD Reveals No Effect on Sweet Taste Intensity Perception and Liking in Humans
- A conversion of oral cannabidiol to delta9-THC seems not to occur in humans
- Clinical and pre-clinical evidence for functional interactions of CBD and THC
- CBD, a novel inverse agonist for GPR12